

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.45117276 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.45117276 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.10528229 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.10528229 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62753329 |
| 6 | exogenous drug catabolic process (GO:0042738) | 6.38731374 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.23706032 |
| 8 | * triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.15881964 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 6.08057378 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.92161840 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.92161840 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.92161840 |
| 13 | kynurenine metabolic process (GO:0070189) | 5.82564176 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.77278065 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.71733864 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.67604290 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.60352147 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.57003889 |
| 19 | regulation of plasminogen activation (GO:0010755) | 5.55486496 |
| 20 | urea cycle (GO:0000050) | 5.51021287 |
| 21 | urea metabolic process (GO:0019627) | 5.51021287 |
| 22 | * high-density lipoprotein particle remodeling (GO:0034375) | 5.44156588 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.40207425 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.39911292 |
| 25 | cysteine metabolic process (GO:0006534) | 5.37835541 |
| 26 | protein carboxylation (GO:0018214) | 5.30225082 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.30225082 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.20160744 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.14535971 |
| 30 | complement activation, alternative pathway (GO:0006957) | 5.12051125 |
| 31 | serine family amino acid catabolic process (GO:0009071) | 5.08725465 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 5.05897126 |
| 33 | bile acid metabolic process (GO:0008206) | 4.94607621 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.86202493 |
| 35 | * reverse cholesterol transport (GO:0043691) | 4.84401480 |
| 36 | regulation of complement activation (GO:0030449) | 4.83240563 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.79128038 |
| 38 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.76495733 |
| 39 | * protein-lipid complex remodeling (GO:0034368) | 4.76495733 |
| 40 | * macromolecular complex remodeling (GO:0034367) | 4.76495733 |
| 41 | homocysteine metabolic process (GO:0050667) | 4.74425458 |
| 42 | phospholipid efflux (GO:0033700) | 4.71873536 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.71863589 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.69356756 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.65914728 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.63879719 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 4.63879719 |
| 48 | intestinal cholesterol absorption (GO:0030299) | 4.62547679 |
| 49 | alpha-amino acid catabolic process (GO:1901606) | 4.61122158 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.55810698 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.55810698 |
| 52 | lysine catabolic process (GO:0006554) | 4.47692160 |
| 53 | lysine metabolic process (GO:0006553) | 4.47692160 |
| 54 | cellular ketone body metabolic process (GO:0046950) | 4.46950828 |
| 55 | ethanol metabolic process (GO:0006067) | 4.43652541 |
| 56 | regulation of apoptotic cell clearance (GO:2000425) | 4.43614602 |
| 57 | plasma lipoprotein particle clearance (GO:0034381) | 4.42118201 |
| 58 | low-density lipoprotein particle remodeling (GO:0034374) | 4.36890699 |
| 59 | coenzyme catabolic process (GO:0009109) | 4.35475030 |
| 60 | glutamate metabolic process (GO:0006536) | 4.34461054 |
| 61 | cholesterol efflux (GO:0033344) | 4.32288753 |
| 62 | glycine metabolic process (GO:0006544) | 4.29853246 |
| 63 | cellular amino acid catabolic process (GO:0009063) | 4.26630957 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 4.25385930 |
| 65 | bile acid and bile salt transport (GO:0015721) | 4.19950321 |
| 66 | plasma lipoprotein particle assembly (GO:0034377) | 4.19674310 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.18001569 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 4.17251030 |
| 69 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.17238487 |
| 70 | amine catabolic process (GO:0009310) | 4.16207538 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.16207538 |
| 72 | drug metabolic process (GO:0017144) | 4.13865803 |
| 73 | negative regulation of hemostasis (GO:1900047) | 4.13608918 |
| 74 | negative regulation of blood coagulation (GO:0030195) | 4.13608918 |
| 75 | serine family amino acid metabolic process (GO:0009069) | 4.12703195 |
| 76 | cellular glucuronidation (GO:0052695) | 4.12622226 |
| 77 | acute-phase response (GO:0006953) | 4.07883125 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 4.04127620 |
| 79 | ethanol oxidation (GO:0006069) | 4.01285281 |
| 80 | fibrinolysis (GO:0042730) | 3.97034794 |
| 81 | regulation of humoral immune response (GO:0002920) | 3.96813049 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.96241407 |
| 83 | arginine metabolic process (GO:0006525) | 3.96230529 |
| 84 | ketone body metabolic process (GO:1902224) | 3.86418074 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.84737861 |
| 86 | drug catabolic process (GO:0042737) | 3.83370074 |
| 87 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81796692 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.79371577 |
| 89 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.77905564 |
| 90 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.77905564 |
| 91 | oxidative demethylation (GO:0070989) | 3.77142634 |
| 92 | negative regulation of lipase activity (GO:0060192) | 3.76789835 |
| 93 | phospholipid homeostasis (GO:0055091) | 3.76295729 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.75692871 |
| 95 | opsonization (GO:0008228) | 3.75540558 |
| 96 | negative regulation of coagulation (GO:0050819) | 3.75294858 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.74416230 |
| 98 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74040236 |
| 99 | cofactor catabolic process (GO:0051187) | 3.73044562 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.72374655 |
| 101 | organic acid catabolic process (GO:0016054) | 3.70654180 |
| 102 | carboxylic acid catabolic process (GO:0046395) | 3.70654180 |
| 103 | short-chain fatty acid metabolic process (GO:0046459) | 3.69169063 |
| 104 | protein activation cascade (GO:0072376) | 3.68219296 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.67582164 |
| 106 | * plasma lipoprotein particle organization (GO:0071827) | 3.64536513 |
| 107 | complement activation (GO:0006956) | 3.63626001 |
| 108 | glucuronate metabolic process (GO:0019585) | 3.63567189 |
| 109 | uronic acid metabolic process (GO:0006063) | 3.63567189 |
| 110 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.63381946 |
| 111 | negative regulation of wound healing (GO:0061045) | 3.62817712 |
| 112 | * cholesterol homeostasis (GO:0042632) | 3.62267505 |
| 113 | * sterol homeostasis (GO:0055092) | 3.55781254 |
| 114 | acetyl-CoA metabolic process (GO:0006084) | 3.55502462 |
| 115 | * protein-lipid complex subunit organization (GO:0071825) | 3.52860074 |
| 116 | flavonoid metabolic process (GO:0009812) | 3.52214274 |
| 117 | positive regulation of hemostasis (GO:1900048) | 3.50790768 |
| 118 | positive regulation of blood coagulation (GO:0030194) | 3.50790768 |
| 119 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.49774423 |
| 120 | negative regulation of protein activation cascade (GO:2000258) | 3.49351602 |
| 121 | negative regulation of complement activation (GO:0045916) | 3.41001655 |
| 122 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.36105711 |
| 123 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.36105711 |
| 124 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.33581641 |
| 125 | proline metabolic process (GO:0006560) | 3.30215892 |
| 126 | negative regulation of digestive system process (GO:0060457) | 3.24280674 |
| 127 | peptidyl-glutamic acid modification (GO:0018200) | 3.20857310 |
| 128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.19984032 |
| 129 | * lipoprotein metabolic process (GO:0042157) | 3.12940520 |
| 130 | regulation of cholesterol metabolic process (GO:0090181) | 3.11854926 |
| 131 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11351345 |
| 132 | positive regulation of extracellular matrix organization (GO:1903055) | 3.11183178 |
| 133 | alkaloid metabolic process (GO:0009820) | 3.11006486 |
| 134 | S-adenosylmethionine metabolic process (GO:0046500) | 3.10956345 |
| 135 | cytolysis (GO:0019835) | 3.08960139 |
| 136 | acute inflammatory response (GO:0002526) | 3.05896682 |
| 137 | phenylpropanoid metabolic process (GO:0009698) | 3.05762637 |
| 138 | positive regulation of coagulation (GO:0050820) | 3.05087468 |
| 139 | negative regulation of lipid transport (GO:0032369) | 3.02099626 |
| 140 | sodium-independent organic anion transport (GO:0043252) | 3.01176309 |
| 141 | regulation of triglyceride metabolic process (GO:0090207) | 2.99659069 |
| 142 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.98065539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.25090401 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.06539706 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.75680996 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42591824 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.35294597 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.91134290 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.78019816 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.96419037 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.84790756 |
| 10 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.12053117 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05191949 |
| 12 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8450973 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.95825295 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.89074571 |
| 15 | * P68_20966046_ChIP-Seq_HELA_Human | 1.88597584 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.84738447 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79380689 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73990108 |
| 19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71031993 |
| 20 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.68608161 |
| 21 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.68589675 |
| 22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64729037 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62053980 |
| 24 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61601452 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60039593 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.58948328 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.57559036 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.55803991 |
| 29 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.53303764 |
| 30 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.51873625 |
| 31 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48796717 |
| 32 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.48562674 |
| 33 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.46031547 |
| 34 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43149245 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39899871 |
| 36 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.39731959 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39628873 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39210502 |
| 39 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38390111 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37820874 |
| 41 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.31328597 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27459741 |
| 43 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25878298 |
| 44 | KDM2B_26808549_Chip-Seq_K562_Human | 1.24028403 |
| 45 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.23051987 |
| 46 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.20269928 |
| 47 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19886775 |
| 48 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18969121 |
| 49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18156676 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17405901 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14424025 |
| 52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.13737654 |
| 53 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.12921308 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12861940 |
| 55 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.12429498 |
| 56 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.09482125 |
| 57 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.08716729 |
| 58 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08285501 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07703857 |
| 60 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07252245 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03315017 |
| 62 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03186388 |
| 63 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.02950480 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01741704 |
| 65 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00629069 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.97535628 |
| 67 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97156677 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95962610 |
| 69 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94968076 |
| 70 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94131191 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93793517 |
| 72 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.93651610 |
| 73 | ERA_21632823_ChIP-Seq_H3396_Human | 0.93199554 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92855936 |
| 75 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.91800465 |
| 76 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.91253853 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.90336746 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89188981 |
| 79 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89164634 |
| 80 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.88691361 |
| 81 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88068984 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87982482 |
| 83 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.86864185 |
| 84 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.86808427 |
| 85 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86579653 |
| 86 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86074613 |
| 87 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.85525031 |
| 88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.85485464 |
| 89 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.85141771 |
| 90 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84981171 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84944530 |
| 92 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84412821 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84316292 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.83761626 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.80895916 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79869389 |
| 97 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76987116 |
| 98 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.75330699 |
| 99 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74963806 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73956248 |
| 101 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70219762 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70219762 |
| 103 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69535155 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.66131029 |
| 105 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65985612 |
| 106 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65836122 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65165692 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64430718 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64243018 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.63727076 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.63585361 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.63568864 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.62467201 |
| 114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.61441367 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.61103466 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.58691848 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.56909004 |
| 118 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.56632251 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.55634253 |
| 120 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54490552 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53860365 |
| 122 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.52244807 |
| 123 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51140360 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50640783 |
| 125 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49838592 |
| 126 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.49572719 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48842410 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.47267828 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.46233572 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45804361 |
| 131 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45721363 |
| 132 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.45626362 |
| 133 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45574770 |
| 134 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.44952111 |
| 135 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44432389 |
| 136 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43964274 |
| 137 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42991391 |
| 138 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.42904631 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42588611 |
| 140 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.42554822 |
| 141 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42508938 |
| 142 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42040523 |
| 143 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.41317997 |
| 144 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41035901 |
| 145 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.40565753 |
| 146 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40333746 |
| 147 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.40333689 |
| 148 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39711242 |
| 149 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.39280158 |
| 150 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.38677779 |
| 151 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38501267 |
| 152 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.37910179 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.37407315 |
| 154 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.37358245 |
| 155 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.35950458 |
| 156 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.35764777 |
| 157 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34999862 |
| 158 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34948113 |
| 159 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.34511710 |
| 160 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34077234 |
| 161 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.34007759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25668430 |
| 2 | MP0005360_urolithiasis | 7.42455768 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.33411474 |
| 4 | MP0005365_abnormal_bile_salt | 6.18747369 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13723815 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14834512 |
| 7 | MP0003252_abnormal_bile_duct | 3.79473677 |
| 8 | MP0009840_abnormal_foam_cell | 3.62285682 |
| 9 | * MP0010329_abnormal_lipoprotein_level | 3.55426700 |
| 10 | MP0005083_abnormal_biliary_tract | 3.18880693 |
| 11 | MP0005332_abnormal_amino_acid | 2.86300397 |
| 12 | MP0003195_calcinosis | 2.72774040 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.64005982 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38798912 |
| 15 | MP0008438_abnormal_cutaneous_collagen | 2.29962577 |
| 16 | MP0001986_abnormal_taste_sensitivity | 2.16139659 |
| 17 | MP0000609_abnormal_liver_physiology | 2.14632096 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.13273240 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.12568856 |
| 20 | MP0003868_abnormal_feces_composition | 1.97477154 |
| 21 | MP0005503_abnormal_tendon_morphology | 1.81655099 |
| 22 | MP0002138_abnormal_hepatobiliary_system | 1.80388144 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.78703327 |
| 24 | MP0002132_abnormal_respiratory_system | 1.65903294 |
| 25 | MP0001764_abnormal_homeostasis | 1.64270640 |
| 26 | MP0005409_darkened_coat_color | 1.63749103 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.62711405 |
| 28 | MP0003011_delayed_dark_adaptation | 1.62456870 |
| 29 | MP0009697_abnormal_copulation | 1.61107198 |
| 30 | MP0001958_emphysema | 1.52462911 |
| 31 | * MP0005584_abnormal_enzyme/coenzyme_acti | 1.51166914 |
| 32 | MP0003136_yellow_coat_color | 1.45159215 |
| 33 | MP0005451_abnormal_body_composition | 1.39839666 |
| 34 | MP0002282_abnormal_trachea_morphology | 1.36593755 |
| 35 | MP0002254_reproductive_system_inflammat | 1.36002680 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.34416328 |
| 37 | MP0000678_abnormal_parathyroid_gland | 1.26093113 |
| 38 | MP0000566_synostosis | 1.26092828 |
| 39 | MP0000604_amyloidosis | 1.25920025 |
| 40 | MP0003186_abnormal_redox_activity | 1.25784639 |
| 41 | MP0002933_joint_inflammation | 1.25737615 |
| 42 | MP0005171_absent_coat_pigmentation | 1.25230897 |
| 43 | MP0005647_abnormal_sex_gland | 1.21030300 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.15746551 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.15624359 |
| 46 | MP0004272_abnormal_basement_membrane | 1.15140773 |
| 47 | MP0000751_myopathy | 1.14449449 |
| 48 | MP0003279_aneurysm | 1.14424572 |
| 49 | * MP0009643_abnormal_urine_homeostasis | 1.13307038 |
| 50 | MP0009764_decreased_sensitivity_to | 1.11005489 |
| 51 | MP0002089_abnormal_postnatal_growth/wei | 1.10255992 |
| 52 | * MP0000598_abnormal_liver_morphology | 1.10232697 |
| 53 | MP0003878_abnormal_ear_physiology | 1.09976114 |
| 54 | MP0005377_hearing/vestibular/ear_phenot | 1.09976114 |
| 55 | MP0003879_abnormal_hair_cell | 1.09008583 |
| 56 | MP0005023_abnormal_wound_healing | 1.08986590 |
| 57 | MP0003690_abnormal_glial_cell | 1.06836930 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.02657255 |
| 59 | MP0000003_abnormal_adipose_tissue | 1.00923259 |
| 60 | MP0009763_increased_sensitivity_to | 0.99951516 |
| 61 | MP0000767_abnormal_smooth_muscle | 0.94937623 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.90393128 |
| 63 | MP0003329_amyloid_beta_deposits | 0.90166495 |
| 64 | MP0005636_abnormal_mineral_homeostasis | 0.88931234 |
| 65 | MP0005275_abnormal_skin_tensile | 0.87603681 |
| 66 | MP0005670_abnormal_white_adipose | 0.87000584 |
| 67 | * MP0009642_abnormal_blood_homeostasis | 0.85091073 |
| 68 | * MP0003656_abnormal_erythrocyte_physiolo | 0.82940995 |
| 69 | MP0004043_abnormal_pH_regulation | 0.82558705 |
| 70 | * MP0008469_abnormal_protein_level | 0.80973055 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.80296982 |
| 72 | MP0001915_intracranial_hemorrhage | 0.79457759 |
| 73 | MP0004130_abnormal_muscle_cell | 0.78448948 |
| 74 | MP0006036_abnormal_mitochondrial_physio | 0.77455673 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.77353479 |
| 76 | MP0002971_abnormal_brown_adipose | 0.75393774 |
| 77 | MP0002108_abnormal_muscle_morphology | 0.75304944 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.75215010 |
| 79 | MP0005408_hypopigmentation | 0.75209326 |
| 80 | * MP0002078_abnormal_glucose_homeostasis | 0.75194519 |
| 81 | MP0001502_abnormal_circadian_rhythm | 0.75158536 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.74065509 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.73898610 |
| 84 | MP0005220_abnormal_exocrine_pancreas | 0.72847731 |
| 85 | MP0001661_extended_life_span | 0.70479376 |
| 86 | MP0005535_abnormal_body_temperature | 0.69641804 |
| 87 | MP0005334_abnormal_fat_pad | 0.66764511 |
| 88 | MP0005330_cardiomyopathy | 0.64871084 |
| 89 | MP0009384_cardiac_valve_regurgitation | 0.62826179 |
| 90 | MP0005266_abnormal_metabolism | 0.62563372 |
| 91 | MP0009053_abnormal_anal_canal | 0.62009615 |
| 92 | MP0005423_abnormal_somatic_nervous | 0.61922901 |
| 93 | MP0005551_abnormal_eye_electrophysiolog | 0.59977900 |
| 94 | MP0000467_abnormal_esophagus_morphology | 0.57540031 |
| 95 | MP0005375_adipose_tissue_phenotype | 0.57320993 |
| 96 | MP0005448_abnormal_energy_balance | 0.56855110 |
| 97 | MP0003075_altered_response_to | 0.55357512 |
| 98 | MP0001270_distended_abdomen | 0.54506430 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.53211633 |
| 100 | MP0001756_abnormal_urination | 0.52929725 |
| 101 | MP0001849_ear_inflammation | 0.52755094 |
| 102 | MP0002060_abnormal_skin_morphology | 0.52746315 |
| 103 | MP0002128_abnormal_blood_circulation | 0.52674722 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.52175982 |
| 105 | MP0006138_congestive_heart_failure | 0.52168235 |
| 106 | MP0005464_abnormal_platelet_physiology | 0.49551339 |
| 107 | MP0005395_other_phenotype | 0.49184059 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.49058687 |
| 109 | MP0008874_decreased_physiological_sensi | 0.48901965 |
| 110 | MP0002822_catalepsy | 0.48145219 |
| 111 | * MP0000639_abnormal_adrenal_gland | 0.47700934 |
| 112 | MP0005508_abnormal_skeleton_morphology | 0.47220610 |
| 113 | MP0005174_abnormal_tail_pigmentation | 0.45930971 |
| 114 | MP0003718_maternal_effect | 0.45469303 |
| 115 | MP0005248_abnormal_Harderian_gland | 0.44629422 |
| 116 | MP0008872_abnormal_physiological_respon | 0.43285549 |
| 117 | MP0005166_decreased_susceptibility_to | 0.43125758 |
| 118 | MP0001853_heart_inflammation | 0.42547165 |
| 119 | MP0000579_abnormal_nail_morphology | 0.41221985 |
| 120 | MP0004883_abnormal_blood_vessel | 0.41080687 |
| 121 | * MP0003953_abnormal_hormone_level | 0.40957144 |
| 122 | MP0009672_abnormal_birth_weight | 0.38837232 |
| 123 | MP0008873_increased_physiological_sensi | 0.38296334 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.38203197 |
| 125 | MP0002928_abnormal_bile_duct | 0.37922308 |
| 126 | * MP0002136_abnormal_kidney_physiology | 0.36053977 |
| 127 | MP0002090_abnormal_vision | 0.34338520 |
| 128 | MP0009115_abnormal_fat_cell | 0.33392511 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.32917581 |
| 130 | MP0002837_dystrophic_cardiac_calcinosis | 0.32725038 |
| 131 | MP0000230_abnormal_systemic_arterial | 0.32487099 |
| 132 | MP0000249_abnormal_blood_vessel | 0.32122119 |
| 133 | MP0002168_other_aberrant_phenotype | 0.30725580 |
| 134 | MP0005164_abnormal_response_to | 0.30349078 |
| 135 | MP0005167_abnormal_blood-brain_barrier | 0.30030305 |
| 136 | MP0005595_abnormal_vascular_smooth | 0.29782728 |
| 137 | MP0002796_impaired_skin_barrier | 0.29279662 |
| 138 | MP0003436_decreased_susceptibility_to | 0.28648076 |
| 139 | MP0001881_abnormal_mammary_gland | 0.28536881 |
| 140 | MP0004381_abnormal_hair_follicle | 0.28404133 |
| 141 | MP0001243_abnormal_dermal_layer | 0.27529966 |
| 142 | MP0002970_abnormal_white_adipose | 0.27106783 |
| 143 | MP0005058_abnormal_lysosome_morphology | 0.25780768 |
| 144 | MP0003724_increased_susceptibility_to | 0.25316840 |
| 145 | MP0003633_abnormal_nervous_system | 0.23351529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.49179366 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.41414840 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.19973936 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.63534596 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56201863 |
| 6 | Xanthomatosis (HP:0000991) | 6.47314140 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.31513141 |
| 8 | Complement deficiency (HP:0004431) | 5.24011908 |
| 9 | * Hyperlipoproteinemia (HP:0010980) | 5.07167304 |
| 10 | Joint hemorrhage (HP:0005261) | 4.82208127 |
| 11 | Hyperammonemia (HP:0001987) | 4.70513279 |
| 12 | * Hypolipoproteinemia (HP:0010981) | 4.54279546 |
| 13 | Hyperglycinemia (HP:0002154) | 4.50608466 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 4.47798526 |
| 15 | Epidermoid cyst (HP:0200040) | 4.44956682 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.39078432 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.35675034 |
| 18 | Ketosis (HP:0001946) | 4.33615366 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.16682322 |
| 20 | * Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.14639674 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.11350689 |
| 22 | Hyperglycinuria (HP:0003108) | 4.07051332 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.06081976 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.06081976 |
| 25 | Fat malabsorption (HP:0002630) | 4.03545467 |
| 26 | Hypoglycemic coma (HP:0001325) | 3.92250066 |
| 27 | * Hypoalphalipoproteinemia (HP:0003233) | 3.78084162 |
| 28 | Abnormality of complement system (HP:0005339) | 3.77540073 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.77498413 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.70011822 |
| 31 | Hypercholesterolemia (HP:0003124) | 3.65567555 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56832258 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36888247 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33501106 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.30592712 |
| 36 | Nephritis (HP:0000123) | 3.25822093 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.13507352 |
| 38 | Spontaneous abortion (HP:0005268) | 3.09481211 |
| 39 | Ketoacidosis (HP:0001993) | 3.09289717 |
| 40 | Steatorrhea (HP:0002570) | 3.08154492 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.05845212 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.97766965 |
| 43 | Myocardial infarction (HP:0001658) | 2.97281709 |
| 44 | Hypochromic microcytic anemia (HP:0004840) | 2.93054809 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.90768383 |
| 46 | Metabolic acidosis (HP:0001942) | 2.77500420 |
| 47 | Thin bony cortex (HP:0002753) | 2.74365771 |
| 48 | Skin nodule (HP:0200036) | 2.74069045 |
| 49 | Protrusio acetabuli (HP:0003179) | 2.72111529 |
| 50 | Vascular calcification (HP:0004934) | 2.66382092 |
| 51 | Systemic lupus erythematosus (HP:0002725) | 2.64524354 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.61644537 |
| 53 | Ulnar bowing (HP:0003031) | 2.60223474 |
| 54 | Hypoglycemic seizures (HP:0002173) | 2.59136710 |
| 55 | Lethargy (HP:0001254) | 2.59050083 |
| 56 | Dicarboxylic aciduria (HP:0003215) | 2.58962058 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.58962058 |
| 58 | Mesangial abnormality (HP:0001966) | 2.58489392 |
| 59 | Purpura (HP:0000979) | 2.57528607 |
| 60 | Turricephaly (HP:0000262) | 2.54021730 |
| 61 | Amyloidosis (HP:0011034) | 2.52007304 |
| 62 | Coronal craniosynostosis (HP:0004440) | 2.47525647 |
| 63 | Gout (HP:0001997) | 2.47205123 |
| 64 | Acanthocytosis (HP:0001927) | 2.47130755 |
| 65 | Abnormal gallbladder morphology (HP:0012437) | 2.44445991 |
| 66 | Mitral stenosis (HP:0001718) | 2.41949482 |
| 67 | Cerebral aneurysm (HP:0004944) | 2.39253407 |
| 68 | Glomerulonephritis (HP:0000099) | 2.39030634 |
| 69 | Cholelithiasis (HP:0001081) | 2.37810888 |
| 70 | Spastic diplegia (HP:0001264) | 2.37710111 |
| 71 | Irritability (HP:0000737) | 2.35911421 |
| 72 | Cardiovascular calcification (HP:0011915) | 2.35108617 |
| 73 | Cerebral edema (HP:0002181) | 2.35010496 |
| 74 | Cholecystitis (HP:0001082) | 2.31036416 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.31036416 |
| 76 | Biconcave vertebral bodies (HP:0004586) | 2.30042487 |
| 77 | Vaginal fistula (HP:0004320) | 2.29658416 |
| 78 | Arthropathy (HP:0003040) | 2.29229016 |
| 79 | Joint stiffness (HP:0001387) | 2.27466188 |
| 80 | Neonatal onset (HP:0003623) | 2.27452306 |
| 81 | Cervical subluxation (HP:0003308) | 2.27206691 |
| 82 | Gingival bleeding (HP:0000225) | 2.24606298 |
| 83 | Sensorimotor neuropathy (HP:0007141) | 2.23718338 |
| 84 | Late onset (HP:0003584) | 2.23301374 |
| 85 | Enlarged kidneys (HP:0000105) | 2.22565342 |
| 86 | Esophageal varix (HP:0002040) | 2.22438891 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16774686 |
| 88 | Malnutrition (HP:0004395) | 2.13410641 |
| 89 | Brushfield spots (HP:0001088) | 2.13284677 |
| 90 | Pancreatitis (HP:0001733) | 2.12464868 |
| 91 | Menorrhagia (HP:0000132) | 2.10499687 |
| 92 | Thrombophlebitis (HP:0004418) | 2.09792023 |
| 93 | Vomiting (HP:0002013) | 2.07681138 |
| 94 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05691971 |
| 95 | Mucopolysacchariduria (HP:0008155) | 2.05683442 |
| 96 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05683442 |
| 97 | Status epilepticus (HP:0002133) | 2.04285632 |
| 98 | Generalized aminoaciduria (HP:0002909) | 2.01443684 |
| 99 | Lymphangioma (HP:0100764) | 2.00992386 |
| 100 | Opisthotonus (HP:0002179) | 2.00385123 |
| 101 | Abnormality of the gallbladder (HP:0005264) | 2.00085129 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99067198 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99067198 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99067198 |
| 105 | Hemorrhage of the eye (HP:0011885) | 1.97558546 |
| 106 | Poikilocytosis (HP:0004447) | 1.96097117 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 1.92565366 |
| 108 | Hydroxyprolinuria (HP:0003080) | 1.92565366 |
| 109 | Peritonitis (HP:0002586) | 1.91564135 |
| 110 | Hypophosphatemic rickets (HP:0004912) | 1.91009137 |
| 111 | Widely patent fontanelles and sutures (HP:0004492) | 1.89747935 |
| 112 | Rickets (HP:0002748) | 1.89605676 |
| 113 | Bronchomalacia (HP:0002780) | 1.87918397 |
| 114 | Epistaxis (HP:0000421) | 1.87742410 |
| 115 | Abnormal delivery (HP:0001787) | 1.83814479 |
| 116 | Renal cortical cysts (HP:0000803) | 1.82802053 |
| 117 | Atrioventricular block (HP:0001678) | 1.81810659 |
| 118 | Abnormality of iron homeostasis (HP:0011031) | 1.81744473 |
| 119 | Elevated hepatic transaminases (HP:0002910) | 1.81603698 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79395530 |
| 121 | Alkalosis (HP:0001948) | 1.79204348 |
| 122 | Confusion (HP:0001289) | 1.77090820 |
| 123 | Back pain (HP:0003418) | 1.75224093 |
| 124 | Pulmonary embolism (HP:0002204) | 1.74873890 |
| 125 | Abnormal cartilage morphology (HP:0002763) | 1.72979483 |
| 126 | Obstructive sleep apnea (HP:0002870) | 1.72927603 |
| 127 | Abnormality of vitamin metabolism (HP:0100508) | 1.72397439 |
| 128 | Acute hepatic failure (HP:0006554) | 1.71995741 |
| 129 | Shallow orbits (HP:0000586) | 1.70267718 |
| 130 | Premature rupture of membranes (HP:0001788) | 1.68747988 |
| 131 | Delayed epiphyseal ossification (HP:0002663) | 1.65727983 |
| 132 | Hypochromic anemia (HP:0001931) | 1.65431023 |
| 133 | Rib fusion (HP:0000902) | 1.65143385 |
| 134 | Aortic aneurysm (HP:0004942) | 1.64917347 |
| 135 | Testicular atrophy (HP:0000029) | 1.64637944 |
| 136 | Increased serum ferritin (HP:0003281) | 1.58773598 |
| 137 | Intestinal fistula (HP:0100819) | 1.58207252 |
| 138 | Abnormality of the Achilles tendon (HP:0005109) | 1.57504402 |
| 139 | Elevated alkaline phosphatase (HP:0003155) | 1.55181174 |
| 140 | Broad metatarsal (HP:0001783) | 1.54266683 |
| 141 | Hypophosphatemia (HP:0002148) | 1.53336909 |
| 142 | Rectovaginal fistula (HP:0000143) | 1.51897293 |
| 143 | Rectal fistula (HP:0100590) | 1.51897293 |
| 144 | Aneurysm (HP:0002617) | 1.51651377 |
| 145 | Neonatal hypoglycemia (HP:0001998) | 1.50817697 |
| 146 | Choanal stenosis (HP:0000452) | 1.49716844 |
| 147 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.49519422 |
| 148 | Vitreoretinal degeneration (HP:0000655) | 1.48471957 |
| 149 | J-shaped sella turcica (HP:0002680) | 1.47629017 |
| 150 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.46348527 |
| 151 | Abnormality of the vitreous humor (HP:0004327) | 1.46208005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.08809224 |
| 2 | SIK1 | 4.93551957 |
| 3 | ERN1 | 4.50932268 |
| 4 | FGFR4 | 4.39926291 |
| 5 | INSRR | 3.11658935 |
| 6 | ERBB4 | 2.77549050 |
| 7 | TAOK3 | 2.66935156 |
| 8 | TRIB3 | 2.51488431 |
| 9 | MAP2K4 | 2.38178092 |
| 10 | WNK4 | 2.28515589 |
| 11 | TNK2 | 2.06088662 |
| 12 | NTRK3 | 2.05505237 |
| 13 | PKN2 | 1.94585962 |
| 14 | SIK2 | 1.87852498 |
| 15 | MAPK11 | 1.82767144 |
| 16 | MST1R | 1.82743396 |
| 17 | MUSK | 1.69587109 |
| 18 | DDR2 | 1.60712433 |
| 19 | LATS1 | 1.58248221 |
| 20 | FGFR2 | 1.57774946 |
| 21 | WNK1 | 1.55936910 |
| 22 | PIK3CG | 1.54679376 |
| 23 | DAPK2 | 1.54154449 |
| 24 | FLT3 | 1.53858249 |
| 25 | TYK2 | 1.49965724 |
| 26 | PTK6 | 1.44460924 |
| 27 | PINK1 | 1.39060678 |
| 28 | CDC42BPA | 1.37250244 |
| 29 | PDGFRA | 1.37047997 |
| 30 | EPHA4 | 1.29843578 |
| 31 | ABL2 | 1.29127665 |
| 32 | MARK2 | 1.23603086 |
| 33 | MAP3K7 | 1.21218881 |
| 34 | MAPK12 | 1.21075991 |
| 35 | PRKAA2 | 1.18580312 |
| 36 | GRK6 | 1.15598684 |
| 37 | JAK2 | 1.15089497 |
| 38 | MYLK | 1.14388915 |
| 39 | NEK9 | 1.11239450 |
| 40 | NLK | 1.10413755 |
| 41 | IRAK3 | 1.09841091 |
| 42 | KDR | 1.07183933 |
| 43 | PRKD2 | 1.06252298 |
| 44 | FRK | 1.03412850 |
| 45 | ERBB2 | 1.00421548 |
| 46 | MAPK4 | 1.00076062 |
| 47 | BLK | 0.98916904 |
| 48 | TYRO3 | 0.95745904 |
| 49 | JAK1 | 0.95107331 |
| 50 | PRKCZ | 0.93037123 |
| 51 | EPHB1 | 0.90681724 |
| 52 | MAP2K3 | 0.90257032 |
| 53 | MAPK7 | 0.88529614 |
| 54 | SGK3 | 0.87122311 |
| 55 | MET | 0.84138170 |
| 56 | PRKACG | 0.83071549 |
| 57 | TBK1 | 0.82031061 |
| 58 | CAMK2G | 0.81863896 |
| 59 | STK38 | 0.79063139 |
| 60 | PDGFRB | 0.78881799 |
| 61 | EPHA3 | 0.77707780 |
| 62 | SGK2 | 0.77521565 |
| 63 | CDK12 | 0.76391212 |
| 64 | TAOK2 | 0.75586820 |
| 65 | MAP3K14 | 0.72546871 |
| 66 | ZAP70 | 0.72527483 |
| 67 | CDK6 | 0.72253582 |
| 68 | PRKCG | 0.70675804 |
| 69 | PRKAA1 | 0.70320289 |
| 70 | CAMK1D | 0.70276680 |
| 71 | STK38L | 0.69729111 |
| 72 | RIPK1 | 0.69392879 |
| 73 | RPS6KA6 | 0.68855545 |
| 74 | MAP3K11 | 0.66580605 |
| 75 | MAP2K6 | 0.66502518 |
| 76 | MAP3K10 | 0.66269624 |
| 77 | RPS6KC1 | 0.65699339 |
| 78 | RPS6KL1 | 0.65699339 |
| 79 | PRKD1 | 0.64933711 |
| 80 | MAPK15 | 0.64293906 |
| 81 | FGFR3 | 0.64108912 |
| 82 | MAP3K3 | 0.63611025 |
| 83 | PRKD3 | 0.63537483 |
| 84 | RPS6KA2 | 0.63448731 |
| 85 | TIE1 | 0.63350521 |
| 86 | NTRK2 | 0.62535265 |
| 87 | PDK2 | 0.61772641 |
| 88 | MELK | 0.61664651 |
| 89 | PTK2B | 0.59811112 |
| 90 | SGK223 | 0.59762660 |
| 91 | SGK494 | 0.59762660 |
| 92 | CSK | 0.58229490 |
| 93 | DYRK1B | 0.57809040 |
| 94 | PDPK1 | 0.57550251 |
| 95 | HIPK2 | 0.57321975 |
| 96 | GSK3A | 0.56423661 |
| 97 | PTK2 | 0.56381163 |
| 98 | AKT3 | 0.54071647 |
| 99 | PRKCQ | 0.54064142 |
| 100 | IGF1R | 0.53249900 |
| 101 | ADRBK1 | 0.52423577 |
| 102 | TLK1 | 0.52294810 |
| 103 | PRKG1 | 0.51057961 |
| 104 | MAP2K2 | 0.49420603 |
| 105 | SMG1 | 0.49294884 |
| 106 | ROCK1 | 0.48715617 |
| 107 | CSF1R | 0.48199312 |
| 108 | TTN | 0.48086180 |
| 109 | MAP3K13 | 0.45474715 |
| 110 | RET | 0.45430975 |
| 111 | TRPM7 | 0.44930574 |
| 112 | MAP2K1 | 0.43901271 |
| 113 | TGFBR2 | 0.42536527 |
| 114 | CDK3 | 0.41724316 |
| 115 | CAMK1 | 0.41432312 |
| 116 | EEF2K | 0.40742435 |
| 117 | SGK1 | 0.40067452 |
| 118 | MAPK3 | 0.39415427 |
| 119 | GRK1 | 0.39161953 |
| 120 | NME1 | 0.39018920 |
| 121 | MAPKAPK3 | 0.38757574 |
| 122 | PKN1 | 0.38382642 |
| 123 | MAP3K5 | 0.36248383 |
| 124 | PRKCA | 0.35990767 |
| 125 | PDK1 | 0.35820274 |
| 126 | CAMK4 | 0.35542619 |
| 127 | IKBKE | 0.35410082 |
| 128 | BMX | 0.35026746 |
| 129 | PIK3CA | 0.34608253 |
| 130 | CSNK1G1 | 0.34351290 |
| 131 | CDK4 | 0.32533891 |
| 132 | EGFR | 0.32445303 |
| 133 | CAMK1G | 0.32015679 |
| 134 | ICK | 0.31210147 |
| 135 | PHKG2 | 0.31192232 |
| 136 | PHKG1 | 0.31192232 |
| 137 | CSNK1G2 | 0.30030488 |
| 138 | MTOR | 0.29572748 |
| 139 | PAK3 | 0.28732492 |
| 140 | FGFR1 | 0.27886339 |
| 141 | MAP3K6 | 0.26652154 |
| 142 | MAP3K1 | 0.24504789 |
| 143 | PRKACB | 0.24363560 |
| 144 | PRKACA | 0.23724717 |
| 145 | RPS6KA3 | 0.23222458 |
| 146 | PBK | 0.22899303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40719942 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.91661716 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.32947443 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.22965777 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07951504 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.79843673 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.75540767 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60585704 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60308665 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55613661 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54748195 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36805011 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15421131 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12976783 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06507759 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06456006 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.92917863 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.92833376 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92116901 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90800848 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88234712 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86667210 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82895233 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82474061 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.77990313 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69743973 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.66615059 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66478312 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.65721010 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63747899 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56921901 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.55123496 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52068755 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49861089 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48041742 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.45935684 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38934797 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36467580 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35472693 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34755081 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33954602 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33933576 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32923410 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24406246 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22770173 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.17737611 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.17656570 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.17137996 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.11166414 |
| 50 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.08644269 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02889669 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99747366 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99528134 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97763800 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94239304 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.93780207 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93167420 |
| 58 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.89754361 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84917759 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80206525 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.79455070 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72979476 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69752805 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.68353318 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67158547 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59427641 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58827262 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58776852 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.54034599 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46067728 |
| 71 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44558134 |
| 72 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40944750 |
| 73 | Prion diseases_Homo sapiens_hsa05020 | 0.33103395 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29945830 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28925310 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27351475 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27300269 |
| 78 | Amoebiasis_Homo sapiens_hsa05146 | 0.26837224 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26110571 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.24407520 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.21841641 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21002289 |
| 83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.20862491 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.19720939 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19410819 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18657301 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.14754397 |
| 88 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13871337 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12690816 |
| 90 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.06428815 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.06121537 |
| 92 | Focal adhesion_Homo sapiens_hsa04510 | 0.05284170 |
| 93 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.04884890 |
| 94 | Cocaine addiction_Homo sapiens_hsa05030 | 0.04022662 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.02521550 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01842547 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01498831 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.01364664 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.2313497 |
| 100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2284511 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2253828 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2183304 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2103569 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2098165 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1903099 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | -0.1871197 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1826240 |
| 108 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1603129 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1579312 |
| 110 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1576984 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1576890 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1279842 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1127521 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0996806 |
| 115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0970302 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0765935 |
| 117 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0688118 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0605475 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0167319 |

